Spermidine, NMN and Endocannabinoids Tested Together in First Human Absorption Trial
A UC Davis pilot study measures how four longevity-linked metabolites absorb into blood and fight postprandial inflammation at escalating doses.
Summary
Researchers at UC Davis conducted a small but pioneering pilot study to track what happens in the bloodstream when healthy adults take four metabolites increasingly linked to longevity: spermidine, nicotinamide, palmitoylethanolamide (PEA), and oleoylethanolamide (OEA). Five young healthy participants took escalating doses alongside a standardized breakfast, and blood was drawn at multiple timepoints. The team measured not just how much of each compound reached circulation, but also how the plasma performed in functional tests — including its ability to reduce inflammation, neutralize oxidative stress, and pull cholesterol out of immune cells. This kind of pharmacokinetic and functional data is foundational for designing future longevity supplement trials, as it informs optimal dosing and timing for each compound.
Detailed Summary
Four metabolites — spermidine, nicotinamide, palmitoylethanolamide (PEA), and oleoylethanolamide (OEA) — have each attracted independent attention as potential longevity-supporting compounds. Spermidine induces autophagy and has been associated with reduced cardiovascular and all-cause mortality. Nicotinamide is a precursor in NAD+ synthesis, a molecule whose decline with age is central to mitochondrial dysfunction. PEA and OEA are endogenous fatty acid amides with anti-inflammatory and metabolic-regulatory roles. Yet until this trial, how these compounds behave together in the human body after oral ingestion remained uncharacterized.
This UC Davis pilot study enrolled five young healthy volunteers in a four-arm crossover design. Participants consumed a standardized breakfast paired with either placebo or one of three escalating dose levels (1x, 2x, or 3x a base formulation) of the combined supplement. Serial blood draws were collected across a postprandial time course to build absorption and clearance profiles for each compound.
Beyond simple pharmacokinetics, the study assessed plasma functionality in clinically meaningful ways. Collected plasma samples were tested for their anti-inflammatory capacity, antioxidant activity, and ability to promote cholesterol efflux from primary human macrophages — a process central to cardiovascular protection and the prevention of foam cell formation in atherosclerosis.
While results from this completed trial have not yet been published in full, the study design is methodologically important. It treats longevity metabolites not merely as compounds to be measured in blood but as functional mediators whose downstream effects on immune and metabolic cells matter. Dose-response characterization across three levels provides the kind of rigorous foundation that preclinical studies rarely offer.
Caveats are significant: the sample size of five subjects is too small for statistical inference, participants were young and healthy rather than the aging adults most likely to benefit, and full results remain unavailable. The summary here is based on the abstract only.
Key Findings
- The trial is the first to measure combined oral absorption kinetics of spermidine, nicotinamide, PEA, and OEA in humans.
- Plasma was tested for anti-inflammatory, antioxidant, and cholesterol efflux function — not just metabolite concentration.
- A dose-escalation design (1x, 2x, 3x) allows identification of a dose-response relationship for each metabolite.
- Postprandial inflammation was the primary condition targeted, relevant to cardiovascular and metabolic aging.
- Results from this completed UC Davis pilot can inform larger, powered longevity supplement trials.
Methodology
A four-arm pilot study in five young healthy subjects used placebo control and three escalating doses of a combination supplement taken with a standardized breakfast. Serial blood plasma samples were collected across a postprandial time course and analyzed for compound concentrations and functional biomarkers including anti-inflammatory activity, antioxidant capacity, and macrophage cholesterol efflux.
Study Limitations
The study enrolled only five participants, making statistical conclusions impossible; findings are hypothesis-generating only. All subjects were young and healthy, so results may not translate directly to older or metabolically compromised individuals who are the primary longevity target population. This summary is based on the abstract only, as the full data has not been published in a peer-reviewed journal.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: